Methylprednisolone Acetate Injectable Suspension
19 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
19
Total Reports
2
Deaths Reported
1050.0%
Death Rate
Active Ingredients
Methylprednisolone Acetate Injectable Suspension
Administration Routes
UnknownSubcutaneousIntramuscular
Species Affected
Cat 18
Dog 1
Most Affected Breeds
Domestic Shorthair 15
Domestic Mediumhair 2
Domestic Longhair 1
Retriever - Labrador 1
Most Reported Reactions
Inappetence 4
Lethargy (see also Central nervous system depression in 'Neurological') 4
Weight loss 3
Other abnormal test result NOS 3
Lack of efficacy - NOS 3
Vomiting 2
Behavioural disorder NOS 2
Hypersalivation 2
Neoplasia NOS 2
Death by euthanasia 2
Pyoderma 2
INEFFECTIVE, ATOPY CONTROL 2
Outcome Breakdown
Outcome Unknown
7 (36.8%)
Recovered/Normal
7 (36.8%)
Ongoing
3 (15.8%)
Euthanized
2 (10.5%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.